Genotype-phenotype correlation in combined deficiency of factor V and factor VIII.
暂无分享,去创建一个
P. Platzer | R. Kaufman | D. Ginsburg | J. Mahlangu | Bin Zhang | F. Peyvandi | M. Callaghan | E. Tuddenham | N. Ozbek | U. Seligsohn | M. Spreafico | A. Yang | Z. Avcı | T. Haw | Chunlei Zheng | K. Marchant | C. Zheng | Petra Platzer
[1] A. Bertomoro,et al. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. , 2008, Blood.
[2] H. Hauri,et al. Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency. , 2008, Blood.
[3] Chris L. P. Wong,et al. Combined factors V and VIII deficiency (F5F8D) in a Chinese family due to compound heterozygosity for nonsense mutations of the LMAN1 gene , 2007, British Journal of Haematology.
[4] Bin Zhang,et al. Receptor-mediated protein transport in the early secretory pathway. , 2007, Trends in biochemical sciences.
[5] A. Viswabandya,et al. Mutations in the MCFD2 gene are predominant among patients with hereditary combined FV and FVIII deficiency (F5F8D) in India , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.
[6] M. Margaglione,et al. A new case of combined factor V and factor VIII deficiency further suggests that the LMAN1 M1T mutation is a frequent cause in Italian patients. , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[7] D. Bellissimo,et al. Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. , 2006, Blood.
[8] H. Hauri,et al. Cargo Selectivity of the ERGIC‐53/MCFD2 Transport Receptor Complex , 2006, Traffic.
[9] V. Wiwanitkit. Spectrum of Bleeding in Acquired Factor V Inhibitor: A Summary of 33 Cases , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[10] J. Jesty,et al. Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[11] M. Morris,et al. Combined factor V – factor VIII deficiency (F5F8D): Compound heterozygosity for two novel truncating mutations in LMAN1 in a consanguineous patient , 2006, Thrombosis and Haemostasis.
[12] R. Kaufman,et al. Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2. , 2006, Blood.
[13] Y. Motomura,et al. Endocytosis and storage of plasma factor V by human megakaryocytes , 2005, Thrombosis and Haemostasis.
[14] D. Mohanty,et al. Mutations in the MCFD2 gene and a novel mutation in the LMAN1 gene in Indian families with combined deficiency of factor V and VIII , 2005, American journal of hematology.
[15] R. Kaufman,et al. LMAN1 and MCFD2 Form a Cargo Receptor Complex and Interact with Coagulation Factor VIII in the Early Secretory Pathway* , 2005, Journal of Biological Chemistry.
[16] A. Chuansumrit,et al. Combined factor V and factor VIII deficiency in a Thai patient: a case report of genotype and phenotype characteristics , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.
[17] M. Long,et al. Endocytosis of plasma‐derived factor V by megakaryocytes occurs via a clathrin‐dependent, specific membrane binding event , 2005, Journal of thrombosis and haemostasis : JTH.
[18] P. Simioni,et al. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet‐derived cofactor , 2005, Journal of thrombosis and haemostasis : JTH.
[19] D. Ginsburg,et al. Familial multiple coagulation factor deficiencies: new biologic insight from rare genetic bleeding disorders , 2004, Journal of thrombosis and haemostasis : JTH.
[20] J. Silveira,et al. Unique in Vivo Modifications of Coagulation Factor V Produce a Physically and Functionally Distinct Platelet-derived Cofactor , 2004, Journal of Biological Chemistry.
[21] D. Ginsburg,et al. A mutation in LMAN1 (ERGIC-53) causing combined factor V and factor VIII deficiency is prevalent in Jews originating from the island of Djerba in Tunisia , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[22] H. Hauri,et al. ER export of ERGIC-53 is controlled by cooperation of targeting determinants in all three of its domains , 2003, Journal of Cell Science.
[23] D. Ginsburg,et al. Biosynthetic origin and functional significance of murine platelet factor V. , 2003, Blood.
[24] D. Ginsburg,et al. The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis. , 2003, Blood.
[25] R. Kaufman,et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex , 2003, Nature Genetics.
[26] B. Dahlbäck,et al. Anti‐factor V auto‐antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding , 2003, Journal of thrombosis and haemostasis : JTH.
[27] M. Olsson,et al. Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies , 2001, Transfusion medicine.
[28] T. Kozuka,et al. Molecular characterization of the ERGIC-53 gene in two Japanese patients with combined factor V–factor VIII deficiency , 2001, Annals of Hematology.
[29] Shetty,et al. Combined factor V and VIII deficiency in Indian population , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.
[30] S. Antonarakis,et al. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Molecular Analysis of the ERGIC-53 Gene in 35 Families With Combined Factor V-Factor VIII Deficiency , 2015 .
[31] R. Kaufman,et al. ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families. , 1999, Blood.
[32] K. Kaushansky,et al. Secretable human platelet-derived factor V originates from the plasma pool. , 1998, Blood.
[33] H. Hauri,et al. Mutations in the ER–Golgi Intermediate Compartment Protein ERGIC-53 Cause Combined Deficiency of Coagulation Factors V and VIII , 1998, Cell.
[34] H. Hauri,et al. The Recycling of ERGIC-53 in the Early Secretory Pathway , 1997, The Journal of Biological Chemistry.
[35] S. Zeinali,et al. The locus for combined factor V-factor VIII deficiency (F5F8D) maps to 18q21, between D18S849 and D18S1103. , 1997, American journal of human genetics.
[36] A. Bittles,et al. The comparative role of consanguinity in infant and childhood mortality in Pakistan , 1997, Annals of human genetics.
[37] J. Kelton,et al. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. , 1996, Blood.
[38] M. Chester,et al. A Rapid and Simple ABO Genotype Screening Method Using a Novel B/O2 versus A/O2 Discriminating Nucleotide Substitution at the ABO Locus , 1995, Vox sanguinis.
[39] P. Mannucci,et al. Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma , 1992, British journal of haematology.
[40] T. L. Cole,et al. Isolation and study of an acquired inhibitor of human coagulation factor V. , 1986, The Journal of clinical investigation.
[41] A. Zivelin,et al. Combined Factor V and Factor VIII Deficiency among Non-Ashkenazi Jews , 1982 .
[42] K. Mann,et al. Radioimmunoassay of factor V in human plasma and platelets. , 1982, Blood.
[43] J. Miletich,et al. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets. , 1978, The Journal of clinical investigation.